Activity and safety of avelumab in high-grade neuroendocrine tumors and poorly differentiated neuroendocrine carcinomas progressive after chemotherapy (AveNEC trial)

Saved in:
Bibliographic Details
Main Authors: Fottner, Christian (Author) , Apostolidis, Leonidas (Author) , Krug, Sebastian (Author) , Rinke, Anja (Author) , Grün, Barbara (Author) , Michl, Patrick (Author) , Gress, Thomas Mathias (Author) , Wagner, Daniel-Christoph (Author) , Roth, Wilfried (Author) , Mettler, Esther Maria (Author) , Topsch, Jana (Author) , Ruckes, Christian Rainer (Author) , Galle, Peter R. (Author) , Weber, Mathias M. (Author)
Format: Article (Journal)
Language:English
Published: 1 March 2025
In: Clinical cancer research
Year: 2025, Volume: 31, Issue: 5, Pages: 860-867
ISSN:1557-3265
DOI:10.1158/1078-0432.CCR-24-2461
Online Access:Resolving-System, lizenzpflichtig: https://doi.org/10.1158/1078-0432.CCR-24-2461
Get full text
Author Notes:Christian Fottner, Leonidas Apostolidis, Sebastian Krug, Anja Rinke, Barbara Grün, Patrick Michl, Thomas M. Gress, Daniel-Christoph Wagner, Wilfried Roth, Esther Mettler, Jana Topsch, Christian Ruckes, Peter R. Galle, and Mathias M. Weber
Description
Physical Description:Online Resource
ISSN:1557-3265
DOI:10.1158/1078-0432.CCR-24-2461